Status:
COMPLETED
Safety and Effectiveness of the Akreos Toric Intraocular Lens.
Lead Sponsor:
Bausch & Lomb Incorporated
Conditions:
Cataract
Astigmatism
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to evaluate the safety and effectiveness of the Akreos Toric IOL following cataract surgery.
Eligibility Criteria
Inclusion
- Subjects must be willing and able to provide written consent on the EC approved Informed Consent form.
- Subjects must require a lens power from 15 to 30 diopters.
Exclusion
- Subjects with any anterior segment pathology for which extracapsular phacoemulsification cataract surgery would be contraindicated.
- Subjects with corneal pathology potentially affecting topography.
Key Trial Info
Start Date :
February 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2012
Estimated Enrollment :
198 Patients enrolled
Trial Details
Trial ID
NCT00825513
Start Date
February 1 2009
End Date
September 1 2012
Last Update
March 25 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept. of Clinical Sciences/ Ophthalmology Umea University Hospital
Umeå, Sweden, SE-901 85